Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk

23 May 2023 (09:30 - 10:05)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Professor Arintaya Phrommintikul

Chiang Mai University, Chiang Mai (Thailand)

3 More presentations in this session

Presentation thumbnail

Left atrial volume index significantly correlates with exercise tolerance of perimenopausal hypertensive women in stage A/B of heart failure.

Doctor K. Janikowski (Lodz, PL)

Abstract Slides

Presentation thumbnail

Prognostic implication of LV dysfunction detected by global longitudinal strain and left ventricular hypertrophy in patients with hypertension

Assistant Professor B. PARK (Daegu, KR)

Abstract Slides

Presentation thumbnail

GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.

Assistant Professor M. Chiarito (Rozzano, IT)

Abstract Slides

Access the full session

Session thumbnail

Heart failure - multi-topics 3

The Event

Event poster

Heart Failure 2023

23 May 2023 09:30 CET

You may be interested in

Congress Presentation

PCSK9 inhibitors and cardiovascular outcomes in AMI-BIRISK patients: a multicenter retrospective study

Congress Presentation

Angiotensin II receptor blockers is associated a decreased left ventricular fibrosis in patients with obstructive hypertrophic cardiomyopathy

Congress Presentation

Patient characteristics and discontinuation patterns amongst renin-angiotensin system inhibitor users in the United Kingdom: analysis using a national primary care database

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources